According to Zacks, “National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska. “
Separately, TheStreet raised shares of National Research Corp. from a “hold” rating to a “buy” rating in a report on Wednesday, August 10th.
Shares of National Research Corp. (NASDAQ:NRCIA) traded up 1.54% during trading on Wednesday, reaching $15.87. 807 shares of the company were exchanged. The stock has a market capitalization of $384.39 million, a PE ratio of 19.50 and a beta of 1.69. National Research Corp. has a one year low of $12.47 and a one year high of $17.42. The stock has a 50-day moving average price of $16.04 and a 200-day moving average price of $14.93.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Friday, September 30th will be issued a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date is Wednesday, September 28th. National Research Corp.’s dividend payout ratio (DPR) is presently 68.09%.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with MarketBeat.com's FREE daily email newsletter.